Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 183036, 8 pages
http://dx.doi.org/10.1155/2015/183036
Research Article

Antimycobacterial and HIV-1 Reverse Transcriptase Activity of Julianaceae and Clusiaceae Plant Species from Mexico

1Instituto de Química, Departamento de Productos Naturales, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
2Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
3Hospital Infantil de México Federico Gómez, Dr. Márquez No. 162, Colonia Doctores, 06720 México, DF, Mexico
4Cátedra CONACyT, Mexico
5Departamento de Productos Naturales, Biología Vegetal y Edafología, Facultad de Farmacia, Universitat de Barcelona, Avenida Diagonal 643, Barcelona, 08028 Catalonia, Spain
6Instituto de Botánica (IBUG), Centro Universitario de Ciencias Biológicas y Agropecuarias, Universidad de Guadalajara, 45221 Zapopan, JAL, Mexico

Received 18 December 2014; Accepted 31 March 2015

Academic Editor: Veronique Seidel

Copyright © 2015 Rocio Gómez-Cansino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Fact sheets on Tuberculosis,” http://www.who.int/mediacentre/factsheets/fs104/en/index.html.
  2. World Health Organization, Global Tuberculosis Report, World Health Organization, Geneva, Switzerland, 2014, http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf.
  3. I. M. Gould, “Antibiotic resistance: the perfect storm,” International Journal of Antimicrobial Agents, vol. 34, supplement 3, pp. S2–S5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. B. Levy and B. Marshall, “Antibacterial resistance worldwide: causes, challenges and responses,” Nature Medicine, vol. 10, no. 12, supplement, pp. S122–S129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Luna-Herrera, M. C. Costa, H. G. González, A. I. Rodrigues, and P. C. Castilho, “Synergistic antimycobacterial activities of sesquiterpene lactones from Laurus spp.,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 3, pp. 548–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. L. Cantrell, S. G. Franzblau, and N. H. Fischer, “Antimycobacterial plant terpenoids,” Planta Medica, vol. 67, no. 8, pp. 685–694, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. B. R. Copp and A. N. Pearce, “Natural product growth inhibitors of Mycobacterium tuberculosis,” Natural Product Reports, vol. 24, no. 2, pp. 278–297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-T. Gutierrez-Lugo and C. A. Bewley, “Natural products, small molecules, and genetics in tuberculosis drug development,” Journal of Medicinal Chemistry, vol. 51, no. 9, pp. 2606–2612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Huerta-Reyes, M. D. C. Basualdo, L. Lozada, M. Jimenez-Estrada, C. Soler, and R. Reyes-Chilpa, “HIV-1 inhibition by extracts of clusiaceae species from Mexico,” Biological and Pharmaceutical Bulletin, vol. 27, no. 6, pp. 916–920, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Rivero-Cruz, L. Acevedo, J. A. Guerrero et al., “Antimycobacterial agents from selected Mexican medicinal plants,” Journal of Pharmacy and Pharmacology, vol. 57, no. 9, pp. 1117–1126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. X. M. Cuevas Figueroa, “A revision of the genus Amphipterygium (Julianaceae),” in Ibugana, pp. 27–47, Uiversidad de Guadalajara, Guadalajara, México, 2005. View at Google Scholar
  12. A. G. Olivera Ortega, M. Soto Hernández, M. Martinez Vázquez, T. Terrazas Salgado, and F. Solares Arenas, “Phytochemical study of cuachalalate (Amphiptherygium adstringens, Schiede ex Schlecht),” Journal of Ethnopharmacology, vol. 68, no. 1–3, pp. 109–113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Huerta-Reyes, M. D. C. Basualdo, F. Abe, M. Jimenez-Estrada, C. Soler, and R. Reyes-Chilpa, “HIV-1 inhibitory compounds from Calophyllum brasiliense leaves,” Biological and Pharmaceutical Bulletin, vol. 27, no. 9, pp. 1471–1475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Z.-Q. Xu, W. W. Barrow, W. J. Suling et al., “Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis,” Bioorganic & Medicinal Chemistry, vol. 12, no. 5, pp. 1199–1207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kashman, K. R. Gustafson, R. W. Fuller et al., “The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum,” Journal of Medicinal Chemistry, vol. 35, no. 15, pp. 2735–2743, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. Butler, “Natural products to drugs: natural product-derived compounds in clinical trials,” Natural Product Reports, vol. 25, no. 3, pp. 475–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. García-Zebadúa, G. A. Magos-Guerrero, M. Mumbrú-Massip et al., “Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico,” Fitoterapia, vol. 82, no. 7, pp. 1027–1034, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. INI, Atlas de las Plantas de la Medicina Tradicional Mexicana, Instituto Nacional Indigenista, Mexico City, México, 1st edition, 1994.
  19. A. Navarrete, B. Avula, V. C. Joshi, X. Ji, P. Hersh, and I. A. Khan, “Quantitative determination of triterpenes from Amphiptherygium adstringens by liquid chromatography and thin-layer chromatography and morphological analysis of cuachalalate preparations,” Journal of AOAC International, vol. 89, no. 1, pp. 1–7, 2006. View at Google Scholar · View at Scopus
  20. L. A. Collins and S. G. Franzblau, “Microplate Alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 5, pp. 1004–1009, 1997. View at Google Scholar · View at Scopus
  21. A. Jimenez-Arellanes, M. Meckes, R. Ramirez, J. Torres, and J. Luna-Herrera, “Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases,” Phytotherapy Research, vol. 17, no. 8, pp. 903–908, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. M. Kelly, A. M. C. Ten Bokum, S. M. O'Leary, M. P. O'Sullivan, and J. Keane, “Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection,” Infection and Immunity, vol. 76, no. 1, pp. 351–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. S. Min, Y. H. Kim, M. Tomiyama et al., “Inhibitory effects of Korean plants on HIV-1 activities,” Phytotherapy Research, vol. 15, no. 6, pp. 481–486, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. G. T. Tan, J. M. Pezzuto, A. D. Kinghorn, and S. H. Hughes, “Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase,” Journal of Natural Products, vol. 54, no. 1, pp. 143–154, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Flynn and J. Chan, “Immunology of tuberculosis,” Annual Review of Immunology, vol. 19, pp. 93–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. C. R. Driver, S. S. Munsiff, J. Li, N. Kundamal, and S. S. Osahan, “Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City,” Clinical Infectious Diseases, vol. 33, no. 10, pp. 1762–1769, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Schwander, S. Rusch-Gerdes, A. Mateega et al., “A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis,” Tubercle and Lung Disease, vol. 76, no. 3, pp. 210–218, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. A. L. Pozniak, R. Miller, and L. P. Ormerod, “The treatment of tuberculosis in HIV-infected persons,” AIDS, vol. 13, no. 4, pp. 435–445, 1999. View at Publisher · View at Google Scholar · View at Scopus